| Authors: |
Richardson DR; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Deal AM; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Mhina CJ; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Duke University Department of Population Health Sciences, Durham, NC, USA., Washko M; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Cole AC; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Crossnohere NL; The Ohio State University, Columbus, OH, USA., Loh KP; Division of Hematology/Oncology, Department of Medicine, James P Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA., Basch E; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wheeler SB; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wood WA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Bridges JFP; The Ohio State University, Columbus, OH, USA., LeBlanc TW; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Bennett AV; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. |
